Veteran biotech executive sees a wave of M&A coming — and a commercial future for gene editing

statnews.com/2025/11/21/biotech-mergers-acqusitions-vc-david-schenkein

Was the public bidding war over weight loss startup Metsera a sign of things to come in the drug industry? Well, venture capitalist David Schenkein isn’t sure we’ll see many more biotech purchasing battles, but he anticipates it’s just the start of a wave of biotech M&A.
“I don’t see M&A…

This story appeared on statnews.com, 2025-11-22 07:53:00.980000.
The Entire Business World on a Single Page. Free to Use →